Abstract
| Original language | English |
|---|---|
| Patent number | US8697845 B2 |
| Priority date | 15/04/14 |
| Publication status | Published - 2 Sep 2010 |
Fingerprint
Cite this
Antibodies specifically directed to a soluble form of CTLA-4. / Ward, Frank James (Inventor); Barker, Robert Norman (Inventor); Dahal, Lekh Nath (Inventor).
Patent No.: US8697845 B2.Research output: Patent
}
TY - PAT
T1 - Antibodies specifically directed to a soluble form of CTLA-4
AU - Ward, Frank James
AU - Barker, Robert Norman
AU - Dahal, Lekh Nath
PY - 2010/9/2
Y1 - 2010/9/2
N2 - The invention provides materials and methods relating to antibodies specific for a soluble form of CTLA-4 (sCLTA-4). Such antibodies have been shown to have a strong boosting effect on antigen-specific human immune responses.
AB - The invention provides materials and methods relating to antibodies specific for a soluble form of CTLA-4 (sCLTA-4). Such antibodies have been shown to have a strong boosting effect on antigen-specific human immune responses.
UR - https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140415&DB=EPODOC&locale=en_EP&CC=US&NR=8697845B2&KC=B2&ND=5
M3 - Patent
M1 - US8697845 B2
ER -